🔎 Trials Near Me

Hem › Steatotisk leversjukdom › Michigan

Kliniska studier för Steatotisk leversjukdom i Michigan

8 studier för Steatotisk leversjukdom söker deltagare vid platser i Michigan.

Städer i Michigan

Officiell studietext (engelska)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Ann Arbor
  • 89bio Clinical Study Site, Clinton Township
  • 89bio Clinical Study Site, Detroit
  • och 2 fler
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Chesterfield
  • 89bio Clinical Study Site, Wyoming
  • 89bio Clinical Study Site, Ypsilanti
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06318169

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

  • University of Michigan, Ann Arbor
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 28 sep. 2026 · NCT05832229

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  • Clinical Research Institute of Michigan, LLC, Clinton Township
  • Great Lakes Research Institute, Southfield
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  • Akero Clinical Study Site, Novi
  • Akero Clinical Study Site, Southfield
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 21 sep. 2026 · NCT06528314

Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease

  • Henry Ford Health System, Detroit
Rekryterar
Ålder 30 till 70 · Alla kön · Uppdaterad 6 aug. 2026 · NCT07646197

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

  • GSK Investigational Site, Detroit
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06613698

Thermoacoustic Method for Estimating Liver Fat Fraction

  • ENDRA Life Sciences, Ann Arbor
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 7 jan. 2026 · NCT07321925

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.